{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:10:02Z","timestamp":1791054602948,"version":"4.1.0"},"reference-count":75,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,4,1]]},"DOI":"10.1093\/jac\/dki057","type":"journal-article","created":{"date-parts":[[2005,3,2]],"date-time":"2005-03-02T20:28:59Z","timestamp":1109795339000},"page":"424-429","source":"Crossref","is-referenced-by-count":70,"title":["Prospects for adenovirus antivirals"],"prefix":"10.1093","volume":"55","author":[{"given":"Paul R.","family":"Kinchington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric G.","family":"Romanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Jerold Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,4]]},"reference":[{"key":"key\n\t\t\t\t20171010195809_R1","unstructured":"Kinchington, P. R., Turse, S. E., Kowalski, R. P. et al. (1994). Use of polymerase chain amplification reaction for the detection of adenoviruses in ocular swab specimens. Investigative Ophthalmology and Visual Science35, 4126\u201334."},{"key":"key\n\t\t\t\t20171010195809_R2","doi-asserted-by":"crossref","unstructured":"Sarantis, H., Johnson, G., Brown, M. et al. (2004). Comprehensive detection and serotyping of human adenoviruses by PCR and sequencing. Journal of Clinical Microbiology42, 3963\u20139.","DOI":"10.1128\/JCM.42.9.3963-3969.2004"},{"key":"key\n\t\t\t\t20171010195809_R3","unstructured":"Gordon, J. S., Aoki, K. & Kinchington, P. R. (1996). Adenovirus keratoconjunctivitis. In Ocular Infection and Immunity (Pepose, J. S., Holland, G. N. & Wilhelmus, K. R. Eds), pp. 877\u201394. Mosby, St Louis, MO, USA."},{"key":"key\n\t\t\t\t20171010195809_R4","unstructured":"Shenk, T. (2001). Adenoviridae: the viruses and their replication. In Fields Virology. (ed. Knipe, D. M., Howley, P. M., Griffin, D. E., et al.), pp. 2265\u2013300. Lippincott Williams and Wilkins, Philadelphia, PA, USA."},{"key":"key\n\t\t\t\t20171010195809_R5","unstructured":"Horwitz, M. S. (2001). Adenoviruses. In Fields Virology, 4th Edn. (ed. Knipe, D. M., Howley, P. M., Griffin, D. E., et al.), pp. 2301\u201325. Lippincott Williams and Wilkins, Philadelphia, PA, USA."},{"key":"key\n\t\t\t\t20171010195809_R6","doi-asserted-by":"crossref","unstructured":"Kojaoghlanian, T., Flomenberg, P. & Horwitz, M. S. (2003). The impact of adenovirus infection on the immunocompromised host. Reviews in Medical Virology13, 155\u201371.","DOI":"10.1002\/rmv.386"},{"key":"key\n\t\t\t\t20171010195809_R7","doi-asserted-by":"crossref","unstructured":"Chakrabarti, S., Milligan, D. W., Moss, P. A. H. et al. (2004). Adenovirus infections in stem cell transplant recipients: Recent developments in understanding of pathogenesis, diagnosis and management. Leukemia and Lymphoma45, 873\u201385.","DOI":"10.1080\/10428190310001628176"},{"key":"key\n\t\t\t\t20171010195809_R8","doi-asserted-by":"crossref","unstructured":"Munoz, F. M., Piedra, P. A. & Demmler, G. J. (1998). Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clinical Infectious Diseases27, 1194\u2013200.","DOI":"10.1086\/514978"},{"key":"key\n\t\t\t\t20171010195809_R9","doi-asserted-by":"crossref","unstructured":"Baldwin, A., Kingman, H., Darville, M. et al. (2000). Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplantation26, 1333\u20138.","DOI":"10.1038\/sj.bmt.1702716"},{"key":"key\n\t\t\t\t20171010195809_R10","doi-asserted-by":"crossref","unstructured":"La Rosa, A. M., Champlin, R. E., Mirza, N. et al. (2001). Adenovirus infections in adult recipients of blood and marrow transplants. Clinical Infectious Diseases32, 871\u20136.","DOI":"10.1086\/319352"},{"key":"key\n\t\t\t\t20171010195809_R11","doi-asserted-by":"crossref","unstructured":"Walls, T., Shankar, A. G. & Shingadia, D. (2003). Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infectious Diseases3, 79\u201386.","DOI":"10.1016\/S1473-3099(03)00515-2"},{"key":"key\n\t\t\t\t20171010195809_R12","doi-asserted-by":"crossref","unstructured":"Chakrabarti, S., Mautner, V., Osman, H. et al. (2002). Adenovirus infections following allogenic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood100, 1619\u201327.","DOI":"10.1182\/blood-2002-02-0377"},{"key":"key\n\t\t\t\t20171010195809_R13","doi-asserted-by":"crossref","unstructured":"Kaneko, H., Mori, S., Suzuki, O. et al. (2004). The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovir. Antiviral Research61, 63\u20136.","DOI":"10.1016\/j.antiviral.2003.08.003"},{"key":"key\n\t\t\t\t20171010195809_R49","doi-asserted-by":"crossref","unstructured":"Trousdale, M. D., Goldschmidt, P. L. & Nobrega, R. (1994). Activity of ganciclovir against human adenovirus type-5 infection in cell-culture and cotton rat eyes. Cornea13, 435\u20139.","DOI":"10.1097\/00003226-199409000-00011"},{"key":"key\n\t\t\t\t20171010195809_R14","doi-asserted-by":"crossref","unstructured":"Mentel, R. & Wegner, U. (2000). Evaluation of the efficacy of 2\u2032,3\u2032-dideoxycytidine against adenovirus infection in a mouse pneumonia model. Antiviral Research47, 79\u201387.","DOI":"10.1016\/S0166-3542(00)00088-7"},{"key":"key\n\t\t\t\t20171010195809_R15","unstructured":"Gordon, Y. J., Romanowski, E. & Araullo-Cruz, T. (1992). An ocular model of adenovirus type-5 infection in the NZ rabbit. Investigative Ophthalmology and Visual Science33, 574\u201380."},{"key":"key\n\t\t\t\t20171010195809_R16","unstructured":"Romanowski, E. G., Araullo-Cruz, T. & Gordon, Y. J. (1998). Multiple adenoviral serotypes demonstrate host range extension in the New Zealand rabbit ocular model. Investigative Ophthalmology and Visual Science39, 532\u20136."},{"key":"key\n\t\t\t\t20171010195809_R17","unstructured":"Gordon, Y. J., Romanowski, E., Araullo-Cruz, T. et al. (1992). Pretreatment with Topical 0.1% (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine inhibits adenovirus type-5 replication in the New-Zealand rabbit ocular model. Cornea11, 529\u201333."},{"key":"key\n\t\t\t\t20171010195809_R18","unstructured":"De Clercq, E. (1996). Therapeutic potential of cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections. Verhandelingen\u2014Koninklijke Academie voor Geneeskunde van Belgie58, 19\u201347."},{"key":"key\n\t\t\t\t20171010195809_R20","doi-asserted-by":"crossref","unstructured":"Kinchington, P. R., Araullo-Cruz, T., Vergnes, J. P. et al. (2002). Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir. Antiviral Research56, 73\u201384.","DOI":"10.1016\/S0166-3542(02)00098-0"},{"key":"key\n\t\t\t\t20171010195809_R21","doi-asserted-by":"crossref","unstructured":"Safrin, S., Cherrington, J. & Jaffe, H. S. (1997). Clinical uses of cidofovir. Reviews in Medical Virology7, 145\u201356.","DOI":"10.1002\/(SICI)1099-1654(199709)7:3<145::AID-RMV196>3.0.CO;2-0"},{"key":"key\n\t\t\t\t20171010195809_R22","unstructured":"Gordon, Y. J., Romanowski, E. G. & Araullo-Cruz, T. (1994). Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model. Investigative Ophthalmology and Visual Science35, 4135\u201343."},{"key":"key\n\t\t\t\t20171010195809_R23","unstructured":"Romanowski, E. G. & Gordon, Y. J. (2000). Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model. Investigative Ophthalmology and Visual Science41, 460\u20133."},{"key":"key\n\t\t\t\t20171010195809_R24","doi-asserted-by":"crossref","unstructured":"Romanowski, E. G., Yates, K. A. & Gordon, Y. J. (2001). Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5\/New Zealand rabbit ocular model. Antiviral Research52, 275\u201380.","DOI":"10.1016\/S0166-3542(01)00166-8"},{"key":"key\n\t\t\t\t20171010195809_R25","doi-asserted-by":"crossref","unstructured":"de Oliveira, C. B., Stevenson, D., LaBree, L. et al. (1996). Evaluation of cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antiviral Research31, 165\u201372.","DOI":"10.1016\/0166-3542(95)00962-0"},{"key":"key\n\t\t\t\t20171010195809_R26","doi-asserted-by":"crossref","unstructured":"De Clercq, E. (1998). Towards an effective chemotherapy of virus infections: therapeutic potential of cidofovir [(S)-1-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine, HPMPC] for the treatment of DNA virus infections. Collection of Czechoslovak Chemical Communications63, 480\u2013506.","DOI":"10.1135\/cccc19980480"},{"key":"key\n\t\t\t\t20171010195809_R27","unstructured":"Romanowski, E. G., Bartels, S. P. & Gordon, Y. J. (1999). Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model. Investigative Ophthalmology and Visual Science40, 378\u201384."},{"key":"key\n\t\t\t\t20171010195809_R28","unstructured":"Romanowski, E. G., Gordon, Y. J., Araullo-Cruz, T. et al. (2001). The antiviral resistance and replication of cidofovir-resistant adenovirus variants in the New Zealand White rabbit ocular model. Investigative Ophthalmology and Visual Science42, 1812\u20135."},{"key":"key\n\t\t\t\t20171010195809_R29","doi-asserted-by":"crossref","unstructured":"Hillenkamp, J., Reinhard, T., Ross, R. S. et al. (2002). The effects of cidofovir 1% with and without cyclosporin A 1% as a topical treatment of acute adenoviral keratoconjunctivitis\u2014a controlled clinical pilot study. Ophthalmology109, 845\u201350.","DOI":"10.1016\/S0161-6420(02)00992-2"},{"key":"key\n\t\t\t\t20171010195809_R30","doi-asserted-by":"crossref","unstructured":"Hillenkamp, J., Reinhard, T., Ross, R. S. et al. (2001). Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study. Archives of Ophthalmology119, 1487\u201391.","DOI":"10.1001\/archopht.119.10.1487"},{"key":"key\n\t\t\t\t20171010195809_R31","doi-asserted-by":"crossref","unstructured":"Bordigoni, P., Carret, A. S., Venard, V. et al. (2001). Treatment of adenovirus infections in patients undergoing allogeneic heamatopoietic stem cell transplantation. Clinical Infectious Diseases32, 1290\u20137.","DOI":"10.1086\/319984"},{"key":"key\n\t\t\t\t20171010195809_R32","doi-asserted-by":"crossref","unstructured":"Carter, B. A., Karpen, S. J., Quiros-Tejeira, R. E. et al. (2002). Intravenous cidofovir therapy for disseminated adenovirus in a paediatric liver transplant recipient. Transplantation74, 1050\u20132.","DOI":"10.1097\/00007890-200210150-00027"},{"key":"key\n\t\t\t\t20171010195809_R33","doi-asserted-by":"crossref","unstructured":"Legrand, F., Berrebi, D., Houhou, N. et al. (2001). Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplantation27, 621\u20136.","DOI":"10.1038\/sj.bmt.1702820"},{"key":"key\n\t\t\t\t20171010195809_R34","doi-asserted-by":"crossref","unstructured":"Ljungman, P., Ribaud, P., Eyrich, M. et al. (2003). Cidofovir for adenovirus infections after allogeneic haematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation31, 481\u20136.","DOI":"10.1038\/sj.bmt.1703798"},{"key":"key\n\t\t\t\t20171010195809_R35","doi-asserted-by":"crossref","unstructured":"Hatakeyama, N., Suzuki, N., Kudoh, T. et al. (2003). Successful cidofovir treatment of adenvirus-associated hemorrhagic cystitis and renal dysfunction after allogeneic bone marrow transplant. Pediatric Infectious Disease Journal22, 928\u20139.","DOI":"10.1097\/01.inf.0000091399.29505.21"},{"key":"key\n\t\t\t\t20171010195809_R36","doi-asserted-by":"crossref","unstructured":"Ribaud, P., Scieux, C., Freymuth, F. et al. (1999). Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient. Clinical Infectious Diseases28, 690\u20131.","DOI":"10.1086\/517222"},{"key":"key\n\t\t\t\t20171010195809_R37","doi-asserted-by":"crossref","unstructured":"Safrin, S., Cherrington, J. & Jaffe, H. S. (1999). Cidofovir. Review of current and potential clinical uses. Advances in Experimental Medicine and Biology458, 111\u201320.","DOI":"10.1007\/978-1-4615-4743-3_10"},{"key":"key\n\t\t\t\t20171010195809_R38","doi-asserted-by":"crossref","unstructured":"Gavin, P. J. & Katz, B. Z. (2002). Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Paediatrics110, e9.","DOI":"10.1542\/peds.110.1.e9"},{"key":"key\n\t\t\t\t20171010195809_R39","doi-asserted-by":"crossref","unstructured":"Aebi, C., Headrick, C. L., McCracken, G. H. et al. (1997). Intravenous ribavirin therapy in a neonate with disseminated adenovirus infection undergoing extracorporeal membrane oxygenation: pharmacokinetics and clearance by hemofiltration. Journal of Paediatrics130, 612\u20135.","DOI":"10.1016\/S0022-3476(97)70246-4"},{"key":"key\n\t\t\t\t20171010195809_R40","doi-asserted-by":"crossref","unstructured":"Miyamura, K., Hamaguchi, M., Taji, H. et al. (2000). Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogeneic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplantation25, 545\u20138.","DOI":"10.1038\/sj.bmt.1702195"},{"key":"key\n\t\t\t\t20171010195809_R41","doi-asserted-by":"crossref","unstructured":"Shetty, A. K., Gans, H. A., So, S. et al. (2000). Intravenous ribavirin therapy for adenovirus pneumonia. Paediatric Pulmonology29, 69\u201373.","DOI":"10.1002\/(SICI)1099-0496(200001)29:1<64::AID-PPUL11>3.0.CO;2-D"},{"key":"key\n\t\t\t\t20171010195809_R42","unstructured":"Jurado, C. M., Hernandez, M. F., Navarro Mari, J. M. et al. (1998). Adenovirus pneumonitis successfully treated with intravenous ribavirin. Haematologica83, 1128\u20139."},{"key":"key\n\t\t\t\t20171010195809_R43","unstructured":"Liles, W. C., Cushing, H., Holt, S. et al. (1993). Severe adenoviral nephritis following bone-marrow transplantation\u2014successful treatment with intravenous ribavirin. Bone Marrow Transplantation12, 409\u201312."},{"key":"key\n\t\t\t\t20171010195809_R44","doi-asserted-by":"crossref","unstructured":"Bertrand, P., Faro, A., Cantwell, P. et al. (2000). Intravenous ribavirin and hyperammonemia in an immunocompromised patient infected with adenovirus. Pharmacotherapy20, 1216\u201320.","DOI":"10.1592\/phco.20.15.1216.34582"},{"key":"key\n\t\t\t\t20171010195809_R45","doi-asserted-by":"crossref","unstructured":"Chakrabarti, S., Collingham, K. E., Fegan, C. D. et al. (1999). Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy. Bone Marrow Transplantation23, 1209\u201311.","DOI":"10.1038\/sj.bmt.1701788"},{"key":"key\n\t\t\t\t20171010195809_R46","doi-asserted-by":"crossref","unstructured":"Mann, D., Moreb, J., Smith, S. et al. (1998). Failure of intravenous ribavirin in the treatment of invasive adenovirus infection following allogeneic bone marrow transplantation: a case report. Journal of Infection36, 227\u20138.","DOI":"10.1016\/S0163-4453(98)80021-2"},{"key":"key\n\t\t\t\t20171010195809_R47","unstructured":"Romanowski, E. G., Yates, K. A., Heiry, M. et al. (2001). Beyond cidofovir: the in vitro evaluation of newer potential antiviral agents against ocular isolates of adenovirus. [Abstract 3107]. Investigative Ophthalmology and Visual Science42, Suppl. S579."},{"key":"key\n\t\t\t\t20171010195809_R48","doi-asserted-by":"crossref","unstructured":"Gordon, J. S., Romanowski, E., Araullo-Cruz, T. et al. (1991). Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2\u2032-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro. Antiviral Research16, 11\u201316.","DOI":"10.1016\/0166-3542(91)90054-U"},{"key":"key\n\t\t\t\t20171010195809_R50","doi-asserted-by":"crossref","unstructured":"Duggan, J. M., Farrehi, J., Duderstadt, S. et al. (1997). Treatment with ganciclovir of adenovirus pneumonia in a cardiac transplant patient. American Journal of Medicine103, 439\u201340.","DOI":"10.1016\/S0002-9343(97)85997-9"},{"key":"key\n\t\t\t\t20171010195809_R51","doi-asserted-by":"crossref","unstructured":"Bruno, B., Gooley, T., Hackman, R. C. et al. (2003). Adenovirus infection in haematopoietic stem cell transplantation: Effect of ganciclovir and impact on survival. Biology of Blood and Marrow Transplantation9, 341\u201352.","DOI":"10.1016\/S1083-8791(03)00102-2"},{"key":"key\n\t\t\t\t20171010195809_R52","doi-asserted-by":"crossref","unstructured":"Mentel, R., Kurek, S., Wegner, U. et al. (2000). Inhibition of adenovirus DNA polymerase by modified nucleoside triphosphate analogs correlate with their antiviral effects on cellular level. Medical Microbiology & Immunology189, 91\u20135.","DOI":"10.1007\/s004300000046"},{"key":"key\n\t\t\t\t20171010195809_R53","doi-asserted-by":"crossref","unstructured":"Mentel, R., Kinder, M., Wegner, U. et al. (1997). Inhibitory activity of 3\u2032-fluoro-2\u2032 deoxythymidine and related nucleoside analogues against adenoviruses in vitro. Antiviral Research34, 113\u20139.","DOI":"10.1016\/S0166-3542(97)01029-2"},{"key":"key\n\t\t\t\t20171010195809_R54","doi-asserted-by":"crossref","unstructured":"Zarubaev, V. V., Sukhinin, V. P., Dyachenko, N. S. et al. (2000). Effect of 6-azacytidine to experimental adenoviral infection. Antiviral Research46, A66.","DOI":"10.1016\/S0166-3542(00)90437-6"},{"key":"key\n\t\t\t\t20171010195809_R55","doi-asserted-by":"crossref","unstructured":"Alexeeva, I., Dyachenko, N., Nosach, L. et al. (2001). 6-Azacytidine\u2014compound with wide spectrum of antiviral activity. Nucleosides Nucleotides & Nucleic Acids20, 1147\u201352.","DOI":"10.1081\/NCN-100002508"},{"key":"key\n\t\t\t\t20171010195809_R56","unstructured":"Kaneko, H., Mori, S., Shigeta, S. et al. (2002). Antiviral effect of NNMS03 against adenovirus in vitro. Investigative Ophthalmology and Visual Science43, E-abstract 4336."},{"key":"key\n\t\t\t\t20171010195809_R57","doi-asserted-by":"crossref","unstructured":"Kaneko, H., Kato, K., Mori, S. et al. (2001). Antiviral activity of NMSO3 against adenovirus in vitro. Antiviral Research52, 281\u20138.","DOI":"10.1016\/S0166-3542(01)00167-X"},{"key":"key\n\t\t\t\t20171010195809_R58","doi-asserted-by":"crossref","unstructured":"Nagl, M., Larcher, C. & Gottardi, W. (1998). Activity of N-chlorotaurine against herpes simplex- and adenoviruses. Antiviral Research38, 25\u201330.","DOI":"10.1016\/S0166-3542(98)00005-9"},{"key":"key\n\t\t\t\t20171010195809_R59","unstructured":"Romanowski, E. G., Yates, K. A., Teuchner, B. et al. (2002). The in vitro evaluation of the new antimicrobial agent N-chlorotaurine (NCT) against ocular isolates of adenovirus. Investigative Ophthalmology & Visual Science43, E-abstract 3858."},{"key":"key\n\t\t\t\t20171010195809_R60","doi-asserted-by":"crossref","unstructured":"Nagl, M., Miller, B., Daxecker, F. et al. (1998). Tolerance of N-chlorotaurine, an endogenous antimicrobial agent, in the rabbit and human eye\u2014a phase I clinical study. Journal of Ocular Pharmacology and Therapeutics14, 283\u201390.","DOI":"10.1089\/jop.1998.14.283"},{"key":"key\n\t\t\t\t20171010195809_R61","doi-asserted-by":"crossref","unstructured":"Nagl, M., Brown, N., Neher, A. et al. (2004). Tolerability of N-chlorotaurine in the guinea pig middle ear: a pilot study using an improved application system. Annals of Otology Rhinology and Laryngology113, 76\u201381.","DOI":"10.1177\/000348940411300117"},{"key":"key\n\t\t\t\t20171010195809_R62","doi-asserted-by":"crossref","unstructured":"Nagl, M., Teuchner, B., Pottinger, E. et al. (2000). Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis\u2014a phase II pilot study. Ophthalmologica214, 111\u20134.","DOI":"10.1159\/000027477"},{"key":"key\n\t\t\t\t20171010195809_R76","unstructured":"Epstein, S. P., Pashinsky, Y. Y., Winicov, I. et al. (2003). Topical cobalt chelate CTC-96 for the treatment of adenovirus conjunctivitis in a rabbit model. Investigative Ophthalmology and Visual Science44, E-abstract 4650."},{"key":"key\n\t\t\t\t20171010195809_R63","unstructured":"Asbell, P. A., Epstein, S. P., Wallace, J. A. et al. (1998). Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis. Cornea17, 550\u20137."},{"key":"key\n\t\t\t\t20171010195809_R64","doi-asserted-by":"crossref","unstructured":"Chiang, L. C., Cheng, H. Y., Liu, M. C. et al. (2003). In vitro anti-herpes simplex viruses and anti-adenoviruses activity of twelve traditionally used medicinal plants in Taiwan. Biological and Pharmaceutical Bulletin26, 1600\u20134.","DOI":"10.1248\/bpb.26.1600"},{"key":"key\n\t\t\t\t20171010195809_R65","doi-asserted-by":"crossref","unstructured":"Weber, J. M., Ruzindana-Umunyana, A., Imbeault, L. et al. (2003). Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Research58, 167\u201373.","DOI":"10.1016\/S0166-3542(02)00212-7"},{"key":"key\n\t\t\t\t20171010195809_R66","doi-asserted-by":"crossref","unstructured":"Zarubaev, V. V., Slita, A. V., Krivitskaya, V. Z. et al. (2003). Direct antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 in vitro. Antiviral Research58, 131\u20137.","DOI":"10.1016\/S0166-3542(02)00193-6"},{"key":"key\n\t\t\t\t20171010195809_R67","doi-asserted-by":"crossref","unstructured":"Arnold, D., Di Biase, A. M., Marchetti, M. et al. (2002). Antiadenovirus activity of milk proteins: lactoferrin prevents viral infection. Antiviral Research53, 153\u20138.","DOI":"10.1016\/S0166-3542(01)00197-8"},{"key":"key\n\t\t\t\t20171010195809_R68","doi-asserted-by":"crossref","unstructured":"Das, A., Trousdale, M. D., Ren, S. et al. (1999). Inhibition of herpes simplex virus type 1 and adenovirus type 5 by heterocyclic Schiff bases of aminohydroxyguanidine tosylate. Antiviral Research44, 201\u20138.","DOI":"10.1016\/S0166-3542(99)00070-4"},{"key":"key\n\t\t\t\t20171010195809_R69","doi-asserted-by":"crossref","unstructured":"Hui, M. B. V., Lien, E. J. & Trousdale, M. D. (1994). Inhibition of human adenoviruses by 1-(2\u2032-hydroxy-5\u2032-methoxybenzylidene)amino-3-hydroxyguanidine tosylate. Antiviral Research24, 261\u201373.","DOI":"10.1016\/0166-3542(94)90074-4"},{"key":"key\n\t\t\t\t20171010195809_R70","unstructured":"Wong, H. K. & Hsu, M. T. (2004). Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome. Journal of Virology64, 691\u20139."},{"key":"key\n\t\t\t\t20171010195809_R71","doi-asserted-by":"crossref","unstructured":"Brown, M. T., McGrath, W. J., Toledo, D. L. et al. (1996). Different modes of inhibition of human adenovirus proteinase, probably a cysteine proteinase, by bovine pancreatic trypsin inhibitor. FEBS Letters388, 233\u20137.","DOI":"10.1016\/0014-5793(96)00569-8"},{"key":"key\n\t\t\t\t20171010195809_R72","doi-asserted-by":"crossref","unstructured":"Sircar, S., Keyvani-Amineh, H. & Weber, J. M. (1996). Inhibition of adenovirus infection with protease inhibitors. Antiviral Research30, 147\u201353.","DOI":"10.1016\/0166-3542(95)06939-9"},{"key":"key\n\t\t\t\t20171010195809_R73","doi-asserted-by":"crossref","unstructured":"Hippenmeyer, P. J., Ruminski, P. G., Rico, J. G. et al. (2002). Adenovirus inhibition by peptidomimetic integrin antagonists. Antiviral Research55, 169\u201378.","DOI":"10.1016\/S0166-3542(02)00021-9"},{"key":"key\n\t\t\t\t20171010195809_R74","doi-asserted-by":"crossref","unstructured":"Bastian, A. & Schafer, H. (2001). Human \u03b1-defensin 1 (HNP-1) inhibits adenoviral infection in vitro. Regulatory Peptides101, 157\u201361.","DOI":"10.1016\/S0167-0115(01)00282-8"},{"key":"key\n\t\t\t\t20171010195809_R75","doi-asserted-by":"crossref","unstructured":"Coen, D. M. & Schaffer, P. A. (2003). Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets. Nature Reviews: Drug Discovery2, 278\u201388.","DOI":"10.1038\/nrd1065"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/55\/4\/424\/2399804\/dki057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T22:00:52Z","timestamp":1507672852000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/55\/4\/424\/801232\/Prospects-for-adenovirus-antivirals"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,1]]},"references-count":75,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,4]]},"published-print":{"date-parts":[[2005,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki057","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,4]]},"published":{"date-parts":[[2005,4,1]]}}}